The diagnosis of MH is primarily clinical, based on the rapid onset of symptoms following exposure to triggering agents. A definitive diagnosis can be made through a muscle biopsy and an in vitro contracture test (IVCT). Genetic testing can also identify mutations in the RYR1 or CACNA1S genes, confirming susceptibility to MH.
